5 results  1 of 1 

1 Effects of the cathepsin K inhibitor with mineral trioxide aggregate cements on osteoclastic activity
Hee-Sun Kim, Soojung Kim, Hyunjung Ko, Minju Song, Miri Kim
Restor Dent Endod.2019;44(2):e17.  Published online 2019 April 23     DOI: http://dx.doi.org/10.5395/rde.2019.44.e17
      
2 Emerging Therapies for Osteoporosis
Michael R. McClung
Endocrinol Metab.2015;30(4):429-435.   Published online 2015 December 31     DOI: http://dx.doi.org/10.3803/EnM.2015.30.4.429
      
3 Peri-implant crevicular fluid levels of cathepsin-K, RANKL, and OPG around standard, short, and mini dental implants after prosthodontic loading
Raif Alan, İsmail Marakoğlu, Seyfullah Haliloğlu
J Periodontal Implant Sci.2015;45(5):169-177.   Published online 2015 October 26     DOI: http://dx.doi.org/10.5051/jpis.2015.45.5.169
      
4 Increased Serum Cathepsin K in Patients with Coronary Artery Disease
Xiang Li, Yuzi Li, Jiyong Jin, Dehao Jin, Lan Cui, Xiangshan Li, Yanna Rei, Haiying Jiang, Guangxian Zhao, Guang Yang, Enbo Zhu, Yongshan Nan, Xianwu Cheng
Yonsei Med J.2014;55(4):912-919.   Published online 2014 June 13     DOI: http://dx.doi.org/10.3349/ymj.2014.55.4.912
      
5 The Effects of Combination Therapy of Cathepsin K Inhibitor and PTH on Change in Bone Mineral Density in an Animal Model of Osteoporosis
Seung Hun Lee, Jung-Min Koh, Young-Sun Lee, Beom-Jun Kim, Je-Yong Choi, Ghi-Su Kim
Endocrinol Metab.2011;26(4):303-309.   Published online 2011 December 21     DOI: http://dx.doi.org/10.3803/EnM.2011.26.4.303
      

 1 of 1